SCHEMBL4189939

SCHEMBL4189939

O=S(=O)(O)OCOS(=O)(=O)O

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.44
TSHR P16473 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
CA5A P35218 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
CA1 P00915 1/20 0.31
NT5E P21589 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
FNTA P49354 1/20 0.30
FNTB P49356 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL22654243 0.96 CA2 (0.41) CA2TSHRTDP1CA5ACA5B
SCHEMBL9568489 0.87 TSHR (0.39) CA2TSHRTDP1
SCHEMBL27409476 0.86 CA2 (0.39) CA2TSHRTDP1CA5ACA5B
SCHEMBL13010274 0.81
SCHEMBL20676809 0.81
SCHEMBL10431357 0.79
SCHEMBL17456406 0.78
SCHEMBL562188 0.77 CA2 (0.44) CA2TSHRTDP1CA5ACA5B
Naphthalene SCHEMBL28414012 0.77 FABP1 (0.37) CA2TSHRTDP1CA1CA9
SCHEMBL6228102 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051687-A1 MALONATE AND FURAN BASED SURFACTANTS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2025-02-13 US claimed
US-20240409844-A1 Method to Prepare Furan-Based Surfactants NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2024-12-12 US claimed
EP-4433465-A1 MALONATE AND FURAN BASED SURFACTANTS Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO (NL) 2024-09-25 EP claimed
EP-4405341-A1 METHOD TO PREPARE FURAN-BASED SURFACTANTS Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO (NL) 2024-07-31 EP claimed
WO-2023091017-A1 MALONATE AND FURAN BASED SURFACTANTS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2023-05-25 WO claimed
EP-4183779-A1 MALONATE AND FURAN BASED SURFACTANTS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2023-05-24 EP claimed
WO-2023048574-A1 METHOD TO PREPARE FURAN-BASED SURFACTANTS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2023-03-30 WO claimed
EP-4155297-A1 METHOD TO PREPARE FURAN-BASED SURFACTANTS Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek TNO (NL) 2023-03-29 EP claimed
EP-4746094-A1 PRESSING DEVICE LG Energy Solution, Ltd. (KR) 2026-05-20 EP disclosed
EP-4730459-A1 BATTERY CELL HEATING DEVICE LG Energy Solution, Ltd. (KR) 2026-04-22 EP disclosed
US-20260045541-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY PRECURSOR, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY MITSUI CHEMICALS, INC. (JP) 2026-02-12 US disclosed
US-20250233206-A1 NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2025-07-17 US disclosed
US-12315883-B2 Non-aqueous electrolyte solution and non-aqueous electrolyte secondary battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2025-05-27 US disclosed
US-12261265-B2 Method for producing lithium fluorosulfonate, lithium fluorosulfonate, nonaqueous electrolytic solution, and nonaqueous electrolytic solution secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2025-03-25 US disclosed
EP-0031253-B1 PROCESS FOR PREPARING 3,4-SUBSTITUTED BENZALDEHYDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-10-05 EP disclosed
EP-0065082-A2 Pyrrolidinone derivatives, their preparation and pharmaceutical compositions containing them THE WELLCOME FOUNDATION LIMITED (GB) 1982-11-24 EP disclosed
US-4335263-A MANY STEPS, STARTING WITH ACETYLATION OF M-CRESOL OR P-CRESOL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-06-15 US disclosed
WO-1981003490-A1 BIOLOGICALLY-ACTIVE TRICYCLIC AMINES,METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AKZO NV (NL) 1981-12-10 WO disclosed
EP-0041293-A1 Biologically-active tricyclic amines, methods for their preparation and pharmaceutical compositions containing same AKZO N.V. (NL) 1981-12-09 EP disclosed
EP-0031253-A1 Process for preparing 3,4-substituted benzaldehydes SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-07-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260045541-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY PRECURSOR, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY NHERF1, LBR, LEF1 CA2 46/4885TSHR 875/4885TDP1 1142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.